Cervical cancer screening: Too many are left unprotected

	Tweet

The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened. A meta-analysis by Spence and colleagues published in the August-September 2007 issue of Preventive Medicine shows that undergoing Pap smears irregularly or never was the primary explanation for the development of invasive cervical cancer, followed by false negative tests and poor follow-up of abnormal results.

Papanicolaou and Traut first reported the usefulness of the Papanicolaou smear (’’Pap test") for detecting neoplastic cervical cells in 1943. 

A smear of cells of the uterine cervix indicating the progression of the cancer’s growing malignity provided a powerful screening tool that became rapidly used after WWII without its efficacy being evaluated in a randomized control trial. In the United States, the Pap test is credited with having halved the annual cervical cancer incidence rate (from 17.2 to 8.0 per 100,000) and mortality rate (from 6.2 to 2.9) from 1973 to 1999. In 2000, 83% of U.S. women age 18 and older who had not had a hysterectomy reported having had a Pap test within the past 3 years. The recent discovery of a vaccine against human papillomavirus (HPV), the main cause of cervical cancer, opens the way to the primary prevention of the disease.

The natural history of cervical cancer progression combined with the availability of an HPV vaccine and an effective screening test indicate that eradication of the disease is a plausible objective. To reach that goal, however, it is important not to give up on the minority of women who do not fully benefit from available prevention methods and unfortunately fail to be reached by health promotion messages. Dr. Eduardo Franco, the study’s principal investigator, commented on the findings: “Cervical cancer is a sentinel disease of inequity. The socio-economic disparity already seen with availability of screening could aggravate if vaccination fails to reach the daughters of women at greatest risk. Like mothers, like daughters; the latter unvaccinated and unprotected by screening will eventually contribute to the sad reality of cervical cancer statistics in the future. The solution is to adopt vaccination and screening as universal strategies, with the latter modified to make cost-effective use of limited resources.”
###

Notes to editors

For more information contact: Eduardo Franco, Departments of Oncology and Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. email:

The article, “Process of care failures in invasive cervical cancer: Systematic review and meta-analysis” appears in Preventive Medicine, Volume 45, number 2-3, August-September 2007, published by Elsevier. Copies of the study are available to the news media by emailing .

Contact: David Evans

212-633-3882
Elsevier

RELATED STORIES:
Hysterectomy for cervical cancer feasible in obese women   Aspirin Merits Testing for Prevention of Cervical Cancer in HIV-Infected Women   Researcher Finds Link Between Chlamydia and Cervical Cancer   The Pill doesn’t affect cervical pre-cancer risk   High HPV Concentrations, Smoking Significantly Raise Risks of Cancer   Annual cervical cancer screening persists, despite recommended guidelines   Health groups issue proposed cervical cancer screening guidelines   Vaccine no replacement for Pap test   High cervical cancer rates sign of larger problems   HPV Clearance Tied to Cervical Cancer Disparity   Weakened RNA Interference Reduces Survival in Ovarian Cancer   Staging of cervical cancer complicating pregnancy   HIV drug stops cervical cancer in laboratory test   HPV tests better for cervical screening - experts   Cervical cancer vaccine gives long protection   IUDs almost halve risk of cervical cancer: study   Gardasil prevents cervical cancer caused by virus   Eight virus types cause almost all cervical cancer   Smoking increases risk cervical cancer   Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types   Girls should get cervical cancer vaccine, panel says   Phenoxodiol Produces Anti-cancer Responses in Women with Cervical Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]